Efficacy and Safety of Topical and Systemic Therapies for Atopic Dermatitis in Patients With Skin of Colour: A Systematic Review

Muhammad Waqas, Inzamam Sarwar, Hirra Junejo, Zohaib Ansari, Ben Alexander Marshall · 2026

Read Efficacy and Safety of Topical and Systemic Therapies for Atopic Dermatitis in Patients With Skin of Colour: A Systematic Review by Muhammad Waqas, Inzamam Sarwar, Hirra Junejo, Zohaib Ansari, Ben Alexander Marshall (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13633756.txt.

Description

Muhammad Waqas and co-authors reviewed eczema treatments in patients with skin of colour, in a 2026 paper. The disease is more common and often worse in these patients, yet the trials behind modern care mostly enrolled white patients. In darker skin the disease can look distinct, and redness-based scores may miss live inflammation. The team searched two databases for studies from 2015 onward that split results by race, ethnicity, or skin type.

Fifteen studies made the cut, covering skin creams, immune-targeted injections, and a class of pills that calm immune signals. Across all classes, patients with skin of colour gained real benefit. Their response rates sat broadly in line with those in lighter skin groups. The studies were too varied to pool into one number, which the authors flag as a gap. They call for trials that enroll and report by skin type from the start.

Catalog record

CREATORMuhammad Waqas, Inzamam Sarwar, Hirra Junejo, Zohaib Ansari, Ben Alexander Marshall
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13633756

Browse the full library · About the Tower of Babel